Australia markets open in 5 hours 3 minutes

Fortress Biotech, Inc. (FBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7900+0.0400 (+2.29%)
As of 02:47PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 33.66M
Enterprise value 37.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.17
Price/book (mrq)1.49
Enterprise value/revenue 0.44
Enterprise value/EBITDA -0.28

Trading information

Stock price history

Beta (5Y monthly) 1.53
52-week change 3-84.23%
S&P500 52-week change 323.06%
52-week high 311.8500
52-week low 31.2400
50-day moving average 31.9246
200-day moving average 33.6257

Share statistics

Avg vol (3-month) 3303.4k
Avg vol (10-day) 3238.3k
Shares outstanding 519.23M
Implied shares outstanding 619.23M
Float 814.26M
% held by insiders 126.31%
% held by institutions 124.49%
Shares short (28 Mar 2024) 41.88M
Short ratio (28 Mar 2024) 45.49
Short % of float (28 Mar 2024) 413.01%
Short % of shares outstanding (28 Mar 2024) 49.79%
Shares short (prior month 29 Feb 2024) 41.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 310 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -71.75%
Operating margin (ttm)-1.58%

Management effectiveness

Return on assets (ttm)-37.68%
Return on equity (ttm)-597.36%

Income statement

Revenue (ttm)84.51M
Revenue per share (ttm)10.42
Quarterly revenue growth (yoy)137.40%
Gross profit (ttm)N/A
EBITDA -133.2M
Net income avi to common (ttm)-68.67M
Diluted EPS (ttm)-8.4700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)80.93M
Total cash per share (mrq)4.21
Total debt (mrq)88.59M
Total debt/equity (mrq)5,582.36%
Current ratio (mrq)1.38
Book value per share (mrq)1.49

Cash flow statement

Operating cash flow (ttm)-128.22M
Levered free cash flow (ttm)-100.12M